Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
about
Interventions for the management of malignant pleural effusions: a network meta-analysisPleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusionModern management of malignant pleural mesotheliomaManagement of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) databaseRandomized controlled trials in malignant pleural mesothelioma surgery-mistakes made and lessons learnedThe effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial.Surgical controversies in mesothelioma: MesoVATS addresses the role of surgical debulkingCan EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence.Current surgical strategies for malignant pleural mesothelioma.The impact of surgical approach on quality of life for pleural malignant mesothelioma.Advances in treatment of mesothelioma.Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy?Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.Comparing approaches to the management of malignant pleural effusions.Management of malignant pleural effusion: challenges and solutions.The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.Surgical and non-surgical management of malignant pleural effusions.Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.The Second Mediterranean Symposium: considering mesothelioma from a local and international perspective.Opening lecture to the Second Mediterranean Symposium in Thoracic Oncology. Foreword.Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery.Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion.Current best practice in the evaluation and management of malignant pleural effusions.Malignant pleural mesothelioma: some progress, but still a long way from cure.Surgery for malignant pleural mesothelioma: an international guidelines review.The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature surveyExtended pleurectomy decortication: the current role
P2860
Q24185776-0F3EBC4C-BA2B-454E-8026-2D2AFECF1A7BQ28830889-8E3DA16F-938E-4806-828A-8E8B60F1BC51Q29248127-87A450BB-FC5E-4EA4-8E68-DB67027F2422Q31117531-A111EB7A-8E34-4D65-8ADD-6C73C454A373Q33871624-A32472F8-6B26-42F8-8ADC-E47E54DE736AQ35274986-8DB8C284-45D8-4C35-9EF8-88C1469D8AACQ36594263-B8CDB6A2-5661-46ED-AB91-4424F9B1AB18Q37204010-FC8F3332-420E-4B68-A0FA-94D4C51985AEQ37277434-1787A36B-08B2-42F9-87ED-9A744E1A5CDCQ38438794-8C8AFE0A-657C-41ED-B318-EC79AA276774Q38641574-B7FD50A6-4FD5-4F1D-9D86-5E473318BDF0Q38679846-916BFA81-9DE3-4344-B897-5D5B46DAF72BQ38800916-0A15CF63-05DB-4FD8-8443-BF380841A6B0Q38935087-C4165DD6-A084-4AAF-9576-21BF4813BE79Q38935092-16EA6F86-5469-4ECE-9BDE-9EB986055D7DQ39041991-19B780E1-1D44-44C3-9273-DA8AE6CD1474Q39158773-39ECC0E1-EF3E-432C-813E-204D9521022AQ39426966-6D7BAA6C-D915-4574-878F-C887F67A6542Q40242222-B35673F9-0A76-494E-99C4-CDB3E1E75227Q46847002-819CB832-2868-4644-BC98-BB02A8132265Q47790609-4304A876-3871-48C3-B080-86305BECD736Q48296869-4AFF820E-5E5E-4E8B-8F84-E56EBFD4E60EQ48296876-B688B2A4-7979-455C-AA59-512B9D65474CQ49708022-DCC03256-DE6E-4C53-B53F-385E7E5C5E5EQ50130460-7E1CDA7D-EB8A-43C0-B950-A439205BABCEQ51434808-EC5D58D1-44BB-4D64-A007-5BD33E583238Q55064382-B3DD1B80-2B4D-473B-95C5-5492EFEA567FQ55263507-CB121431-B054-4999-BAD0-3380BB49D1CDQ55339037-82D650E2-51AE-490E-A9AB-7CE5D18A39A3Q59132459-3171C2BF-07E4-4328-954F-D0B5CF9FBD7FQ59137558-A5265E5F-D962-4B0A-A1E6-94CBCD44D396
P2860
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Efficacy and cost of video-ass ...... randomised, controlled trial.
@en
Efficacy and cost of video-ass ...... randomised, controlled trial.
@nl
type
label
Efficacy and cost of video-ass ...... randomised, controlled trial.
@en
Efficacy and cost of video-ass ...... randomised, controlled trial.
@nl
prefLabel
Efficacy and cost of video-ass ...... randomised, controlled trial.
@en
Efficacy and cost of video-ass ...... randomised, controlled trial.
@nl
P2093
P50
P1433
P1476
Efficacy and cost of video-ass ...... randomised, controlled trial.
@en
P2093
Aman S Coonar
Andrew J Ritchie
David A Waller
Eleonora Lovato
John G Edwards
Maxine Bennett
MesoVATS Collaborators
Victoria Hughes
P304
P356
10.1016/S0140-6736(14)60418-9
P407
P577
2014-06-16T00:00:00Z